Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- W81K0023F0133
- Awardee
-
Lantheus Medical Imaging, Inc. UEI ZBTPKVDXCKJ7 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $15,000
Award facts
- Contract value 100% obligated
- $15,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Bliss, TX 79918, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$85,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $100,000 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other federal healthcare institutions.
The parent company, Lantheus Holdings, Inc., is a leading global provider of innovative diagnostic and therapeutic agents, with a focus on specialized medical imaging technologies. Lantheus Medical Imaging, Inc. has secured several significant Indefinite Delivery Vehicles (IDVs) with the DHA and Department of Veterans Affairs, including a $6.5 million BPA for diagnostic nuclear imaging supplies and a $1 million BPA for radiopharmaceuticals. These IDVs, established under the Pharmaceuticals and Drugs GSA Schedule, demonstrate the company's strategic positioning as a specialized supplier of critical medical imaging products to federal healthcare agencies.
Quick answers
Who was awarded contract W81K0023F0133?
W81K0023F0133 was awarded to Lantheus Medical Imaging, Inc. by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W81K0023F0133 worth?
The government has obligated $15,000 on W81K0023F0133.
Which agency awarded contract W81K0023F0133?
Medical Command (Department of the Army) awarded W81K0023F0133, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0023F0133 an order under another contract?
Yes. W81K0023F0133 is a BPA call under W81K0020A0013, a blanket purchase agreement.
Was contract W81K0023F0133 competed?
The extent of competition for W81K0023F0133 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award